ArticleFrontiers in immunology2023

Development of a bivalent protein-based vaccine candidate against invasive pneumococcal diseases based on novel pneumococcal surface protein A in combination with pneumococcal histidine triad protein D.

Elnaz Afshari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.